Diabetes drugs cleared of vascular harm

Two studies suggest that neither sulfonylureas nor sitagliptin increase the risk of adverse cardiovascular outcomes in patients with Type 2 diabetes.
Source: MedWire News - Category: Consumer Health News Tags: Diabetes Source Type: news